ProCE Banner Activity

Conversas sobre o câncer: o cenário terapêutico em expansão para inibidores de CDK4/6 em câncer de mama HR-positivo/HER2-negativo

PDF

Read these slide notes translated in Brazilian Portuguese to follow along with the associated downloadable slideset providing an overview of CDK4/6 inhibitors in HR+/HER2- breast cancer from early stage through metastatic disease.

Released: August 19, 2024

Expiration: August 18, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation